Showing results (11-20 of 39) with videos related to

Sort By:
Pageof 4
British Journal of Haematology|November 11, 1999
Spontaneous and cytokine-induced thrombocytopenia in myelodysplastic syndromes: serum thrombopoietin levels and bone marrow morphology. Scandinavian MDS Group, Sweden and NorwayE Hellström-Lindberg, L Kanter-Lewensohn, J Nichol, et al.
Haematologica|November 27, 1998
A patient-oriented approach to treatment of myelodysplastic syndromesM Cazzola, J E Anderson, A Ganser, et al.
Leukemia Research|November 1, 1993
Variable growth in vitro of chromosomally different stem cells in myelodysplastic syndromesB Swolin, I H Kristiansen, S Rödjer, et al.
Leukemia Research|February 28, 2001
High-dose chemotherapy and APSCT as a potential cure for relapsing hemolysing AILDJ Lindahl, E Kimby, B Björkstrand, et al.
European Journal of Haematology|March 1, 1996
Analysis of CD34-positive cells in bone marrow from patients with myelodysplastic syndromes and acute myeloid leukemia and in normal individuals: a comparison between FACS analysis and immunohistochemistryL Kanter-Lewensohn, E Hellström-Lindberg, Y Kock, et al.
American Journal of Hematology|December 1, 1993
Recombinant human granulocyte-macrophage colony-stimulating factor plus recombinant human erythropoietin may improve anemia in selected patients with myelodysplastic syndromesP B Hansen, H E Johnsen, E Hippe, et al.
Bone Marrow Transplantation|August 22, 2002
The effect of modulation of glutathione cellular content on busulphan-induced cytotoxicity on hematopoietic cells in vitro and in vivoZ Hassan, E Hellström-Lindberg, S Alsadi, et al.
American Journal of Hematology|June 1, 1995
Peripheral blood neutrophil morphology reflects bone marrow dysplasia in myelodysplastic syndromesS Widell, E Hellström-Lindberg, Y Kock, et al.
Leukemia|June 22, 1999
Cleavage of Bcl-2 is an early event in chemotherapy-induced apoptosis of human myeloid leukemia cellsB Fadeel, Z Hassan, E Hellström-Lindberg, et al.
Leukemia Research|January 1, 1992
In vitro suspension culture reactions to 1,25 dihydroxyvitamin D3 in relation to bone marrow morphology and prognosis in patients with myelodysplastic syndromesE Hellström-Lindberg, K H Robèrt, B Ahnsén, et al.
Pageof 4